Cryo-Cell International Balance Sheet

Financials in millions USD. Fiscal year is December - November.

Millions USD. Fiscal year is Dec - Nov.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '25 Nov 30, 2025	Nov '24 Nov 30, 2024	Nov '23 Nov 30, 2023	Nov '22 Nov 30, 2022	Nov '21 Nov 30, 2021
Cash & Equivalents	0.32	0.56	0.41	1.7	8.26
Short-Term Investments	2.98	2.94	0.57	0.02	0.08
Cash & Short-Term Investments	3.3	3.5	0.98	1.72	8.34
Cash Growth	-5.72%	256.66%	-43.06%	-79.35%	-20.20%
Accounts Receivable	6.85	7.31	6.58	6.04	5.25
Inventory	0.41	0.66	0.77	0.85	0.92
Other Current Assets	1.21	1.09	1.13	0.99	1.27
Total Current Assets	11.76	12.55	9.45	9.61	15.78
Net Property, Plant & Equipment	21.85	22.7	22.03	14.21	4.15
Other Intangible Assets	0.86	0.92	0.99	15.15	16.19
Goodwill	1.94	1.94	1.94	1.94	12.01
Long-Term Investments	-	-	0.31	0.31	0.31
Other Long-Term Assets	24.54	22.39	26.5	23.66	12.22
Total Assets	61.73	64.68	61.22	64.89	60.66
Accounts Payable	2.87	1.88	3.17	1.61	1.49
Accrued Expenses	4.28	5.81	5.17	3.59	3.06
Short-Term Debt	2.3	3.52	1.22	2.27	-
Current Portion of Long-Term Debt	0.18	0.17	0.17	0.15	1.9
Current Portion of Leases	0.43	0.43	0.23	0.3	0.31
Unearned Revenue	9.73	9.79	9.7	9.59	9.36
Other Current Liabilities	-	-	1.2	1.98	4.96
Total Current Liabilities	19.79	21.6	20.86	19.48	21.07
Long-Term Debt	8.17	8.31	8.43	8.58	-
Long-Term Leases	0.47	0.51	0.85	0.31	0.61
Other Long-Term Liabilities	51.9	47.48	42.11	38.04	34.79
Total Long-Term Liabilities	60.54	56.29	51.39	46.93	35.4
Total Liabilities	80.33	77.89	72.25	66.41	56.48
Common Stock	0.15	0.15	0.15	0.15	0.15
Treasury Stock	-25.03	-24.86	-23.43	-22.63	-20.81
Additional Paid-in Capital	44.71	44.27	43.41	42.6	41.59
Retained Earnings	-38.44	-32.78	-31.16	-21.64	-16.74
Shareholders' Equity	-18.61	-13.22	-11.03	-1.52	4.18
Total Liabilities & Equity	61.73	64.68	61.22	64.89	60.66
Total Debt	11.56	12.93	10.9	11.61	2.82
Net Cash (Debt)	-8.26	-9.44	-9.92	-9.89	5.52
Net Cash Growth	-	-	-	-	31.08%
Net Cash Per Share	-1.02	-1.15	-1.19	-1.17	0.66
Book Value	-18.61	-13.22	-11.03	-1.52	4.18
Book Value Per Share	-2.31	-1.61	-1.32	-0.18	0.50
Tangible Book Value	-21.41	-16.08	-13.96	-18.62	-24.02
Tangible Book Value Per Share	-2.65	-1.96	-1.67	-2.19	-2.87

Updated Nov 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q